ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 72 filers reported holding ESSA PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,463,288 | +15.6% | 473,556 | +1.0% | 0.00% | 0.0% |
Q2 2023 | $1,266,305 | +101611.2% | 469,002 | +11.9% | 0.00% | 0.0% |
Q1 2023 | $1,245 | +183.0% | 419,067 | +140.2% | 0.00% | – |
Q4 2022 | $440 | -99.9% | 174,475 | -57.1% | 0.00% | – |
Q3 2022 | $740,000 | -28.1% | 406,761 | +24.5% | 0.00% | -100.0% |
Q2 2022 | $1,029,000 | -17.6% | 326,730 | +61.7% | 0.00% | 0.0% |
Q1 2022 | $1,249,000 | -35.1% | 202,047 | +49.1% | 0.00% | 0.0% |
Q4 2021 | $1,925,000 | -3.2% | 135,550 | -45.5% | 0.00% | 0.0% |
Q3 2021 | $1,989,000 | +211.8% | 248,687 | +1014.3% | 0.00% | – |
Q2 2021 | $638,000 | -45.0% | 22,318 | -44.2% | 0.00% | -100.0% |
Q1 2021 | $1,161,000 | +138.9% | 39,969 | -2.0% | 0.00% | – |
Q4 2020 | $486,000 | +11.7% | 40,769 | -35.3% | 0.00% | -100.0% |
Q3 2020 | $435,000 | – | 62,976 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 8,748,629 | $15,923,000 | 0.66% |
Soleus Capital Management, L.P. | 2,640,539 | $4,806,000 | 0.65% |
Omega Fund Management, LLC | 328,196 | $597,000 | 0.22% |
MPM BioImpact LLC | 405,700 | $738,000 | 0.18% |
Bellevue Group AG | 5,898,583 | $10,736,000 | 0.15% |
Rhenman & Partners Asset Management AB | 375,000 | $1,350,000 | 0.14% |
PFM Health Sciences, LP | 1,478,252 | $2,690,000 | 0.10% |
Frazier Life Sciences Management, L.P. | 692,910 | $1,261,000 | 0.10% |
Avidity Partners Management LP | 2,460,000 | $4,477,000 | 0.09% |
Eventide Asset Management | 1,561,251 | $2,841,000 | 0.06% |